<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">21347</article-id><article-id pub-id-type="doi">10.7554/eLife.21347</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Structural basis for inhibition of erythrocyte invasion by antibodies to <italic>Plasmodium falciparum</italic> protein CyRPA</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-17012"><name><surname>Chen</surname><given-names>Lin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17249"><name><surname>Xu</surname><given-names>Yibin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69288"><name><surname>Wong</surname><given-names>Wilson</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69289"><name><surname>Thompson</surname><given-names>Jennifer K</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17250"><name><surname>Healer</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69290"><name><surname>Goddard-Borger</surname><given-names>Ethan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17253"><name><surname>Lawrence</surname><given-names>Michael C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16287"><name><surname>Cowman</surname><given-names>Alan F</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5145-9004</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>The Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff2"><institution>The Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Parkville</named-content></addr-line>, <country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-2915"><name><surname>Harrison</surname><given-names>Stephen C.</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>cowman@wehi.edu.au</email> (AC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>02</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e21347</elocation-id><history><date date-type="received"><day>12</day><month>09</month><year>2016</year></date><date date-type="accepted"><day>31</day><month>01</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Chen et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-21347-v1.pdf"/><abstract><p><italic>Plasmodium falciparum</italic> causes malaria in humans with over 450,000 deaths annually. The asexual blood stage involves invasion of erythrocytes by merozoites, in which they grow and divide to release daughter merozoites, which in turn invade new erythrocytes perpetuating the cycle responsible for malaria. A key step in merozoite invasion is the essential binding of PfRh5/CyRPA/PfRipr complex to basigin, a step linked to formation of a pore between merozoites and erythrocytes. We show CyRPA interacts directly with PfRh5. An invasion inhibitory monoclonal antibody to CyRPA blocks binding of CyRPA to PfRh5 and complex formation thus illuminating the molecular mechanism for inhibition of parasite growth. We determined the crystal structures of CyRPA alone and in complex with antibody Fab fragment. CyRPA has a six-bladed β-propeller fold, and we identify the region that interacts with PfRh5. This functionally conserved epitope is a potential target for vaccines against <italic>P. falciparum</italic>.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>P. falciparum</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Victorian State Government OIS and NHMRC IRIISS</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chen</surname><given-names>Lin</given-names></name><name><surname>Xu</surname><given-names>Yibin</given-names></name><name><surname>Wong</surname><given-names>Wilson</given-names></name><name><surname>Thompson</surname><given-names>Jennifer K</given-names></name><name><surname>Goddard-Borger</surname><given-names>Ethan</given-names></name><name><surname>Lawrence</surname><given-names>Michael C</given-names></name><name><surname>Cowman</surname><given-names>Alan F</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>55007645</award-id><principal-award-recipient><name><surname>Cowman</surname><given-names>Alan F</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>637406</award-id><principal-award-recipient><name><surname>Cowman</surname><given-names>Alan F</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Path/Malaria Vaccine Initiative</institution></institution-wrap></funding-source><award-id>07608-COL</award-id><principal-award-recipient><name><surname>Cowman</surname><given-names>Alan F</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000200</institution-id><institution>United States Agency for International Development</institution></institution-wrap></funding-source><award-id>07608-COL</award-id><principal-award-recipient><name><surname>Cowman</surname><given-names>Alan F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-21347-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>